Business, energy, technology, markets and global industry news from Business News Today

Vero Bioscience

PharmaDeviceNews Vero Bioscience
Vero Bioscience is combining Stanford University’s proteomic organ-aging and Cell Clock technologies to develop OrganAge, a blood-based platform designed to assess biological aging across organs and cell types as the company moves toward broader consumer availability in 2027. Representative image.
Medical Devices & Diagnostics

Can one blood test reveal which cells are aging fastest? Vero brings Stanford Cell Clock into OrganAge

Vero adds Stanford Cell Clock technology to OrganAge ahead of a 2027 rollout, while clinical validation remains the key commercial test.

Read More